Media Inquiries
For inquiries, please contact mediarelations@vyriad.com
October 21, 2021
A COVID-19 booster vaccine that can be given by mouth to people who already have antibodies from vaccination or prior infection has yielded promising results in monkeys and is likely to be tested soon in humans, according to the company developing it. A report of the study posted on Monday on bioRxiv ahead of peer review says Vyriad is working with the U.S. Food and Drug Administration to plan human trials.
For inquiries, please contact mediarelations@vyriad.com